


liquiCORE 52 gene panel is a Next Generation Sequencing (NGS) based assay that identifies clinically relevant genomic alterations (SNVs, short indels, fusions and CNVs) within the 52 genes that are most frequently al-tered in majority of cancers, including, lung, breast, colorectal, melanoma, prostate, ovarian, gastric, bladder,brain, CNS, cervical, endometrial, esophageal, head & neck, kidney, liver, pancreatic, sarcoma, thyroid and endometrial.